Antibiotic Resistance: Challenges and Opportunities, An Issue of Infectious Disease Clinics of North America, E-Book

Nonfiction, Health & Well Being, Medical, Ailments & Diseases, Infectious Diseases, General, Reference
Cover of the book Antibiotic Resistance: Challenges and Opportunities, An Issue of Infectious Disease Clinics of North America, E-Book by Robert A. Bonomo, MD, Richard R. Watkins, MD, MS, FACP, Elsevier Health Sciences
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: Robert A. Bonomo, MD, Richard R. Watkins, MD, MS, FACP ISBN: 9780323446198
Publisher: Elsevier Health Sciences Publication: June 11, 2016
Imprint: Elsevier Language: English
Author: Robert A. Bonomo, MD, Richard R. Watkins, MD, MS, FACP
ISBN: 9780323446198
Publisher: Elsevier Health Sciences
Publication: June 11, 2016
Imprint: Elsevier
Language: English

For many years, physicians and the public assumed that the discovery of new antimicrobial agents would outpace the ability of bacteria to mutate and develop drug resistance. Yet the development of new antibiotics has not kept up with bacterial evolution, especially since the late 1990’s. At that time a multitude of pharmaceutical companies abandoned antibiotic research because of strong economic disincentives. For example, it is challenging for these companies to recuperate the investment (typically in the hundreds of millions of dollars) made in developing a new antibiotic, which is typically prescribed for a few days, compared to drugs that treat chronic conditions like heart disease or mental illness. This situation has led the U.S. federal government to take a more active lead in addressing antibiotic resistance. Recently, the White House announced an action plan that includes improving surveillance, developing better diagnostic tools, accelerating drug development, and improving global coordination of antibiotic resistance issues. Equally important is the $1.2 billion dollars that has been pledged to fund these efforts. While we await the implementation of new policies, this issue of Infectious Disease Clinics of North America brings together leading authorities in the field of antibiotic resistance who discuss current issues including antibiotic stewardship, the changing role of the microbiology laboratory in determining antibiotic resistance in gram-negative pathogens, the continuing spread of metallo-β-lactamases, ESBLs and KPCs, antibiotic options for treating resistant gram-negative infections such as colistin and tigecycline, resistance mechanisms and new treatment options for Mycobacterium tuberculosis, emerging resistance mechanisms in aminoglycosides, issues with antibiotic resistance in immunocompromised patients, new β-lactamase inhibitors in the clinic, and resistance in VRE and Staphylococcus aureus. Additionally, combination therapy for resistant gram-negative infections has been advocated by some authorities and the advantages and disadvantages of this strategy will be reviewed.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

For many years, physicians and the public assumed that the discovery of new antimicrobial agents would outpace the ability of bacteria to mutate and develop drug resistance. Yet the development of new antibiotics has not kept up with bacterial evolution, especially since the late 1990’s. At that time a multitude of pharmaceutical companies abandoned antibiotic research because of strong economic disincentives. For example, it is challenging for these companies to recuperate the investment (typically in the hundreds of millions of dollars) made in developing a new antibiotic, which is typically prescribed for a few days, compared to drugs that treat chronic conditions like heart disease or mental illness. This situation has led the U.S. federal government to take a more active lead in addressing antibiotic resistance. Recently, the White House announced an action plan that includes improving surveillance, developing better diagnostic tools, accelerating drug development, and improving global coordination of antibiotic resistance issues. Equally important is the $1.2 billion dollars that has been pledged to fund these efforts. While we await the implementation of new policies, this issue of Infectious Disease Clinics of North America brings together leading authorities in the field of antibiotic resistance who discuss current issues including antibiotic stewardship, the changing role of the microbiology laboratory in determining antibiotic resistance in gram-negative pathogens, the continuing spread of metallo-β-lactamases, ESBLs and KPCs, antibiotic options for treating resistant gram-negative infections such as colistin and tigecycline, resistance mechanisms and new treatment options for Mycobacterium tuberculosis, emerging resistance mechanisms in aminoglycosides, issues with antibiotic resistance in immunocompromised patients, new β-lactamase inhibitors in the clinic, and resistance in VRE and Staphylococcus aureus. Additionally, combination therapy for resistant gram-negative infections has been advocated by some authorities and the advantages and disadvantages of this strategy will be reviewed.

More books from Elsevier Health Sciences

Cover of the book Primary Care of the Child With a Chronic Condition E-Book by Robert A. Bonomo, MD, Richard R. Watkins, MD, MS, FACP
Cover of the book Principles of Echocardiography E-Book by Robert A. Bonomo, MD, Richard R. Watkins, MD, MS, FACP
Cover of the book Bioinformatics by Robert A. Bonomo, MD, Richard R. Watkins, MD, MS, FACP
Cover of the book Merrill's Atlas of Radiographic Positioning and Procedures E-Book by Robert A. Bonomo, MD, Richard R. Watkins, MD, MS, FACP
Cover of the book Diagnostic Cytology and Hematology of the Horse E-Book by Robert A. Bonomo, MD, Richard R. Watkins, MD, MS, FACP
Cover of the book Tendon Transfers In the Foot and Ankle, An Issue of Foot and Ankle Clinics - E-Book by Robert A. Bonomo, MD, Richard R. Watkins, MD, MS, FACP
Cover of the book Prenatal Screening and Diagnosis, An Issue of Clinics in Laboratory Medicine - E-Book by Robert A. Bonomo, MD, Richard R. Watkins, MD, MS, FACP
Cover of the book Management of Peri-operative Complications, An Issue of Surgical Clinics - E-Book by Robert A. Bonomo, MD, Richard R. Watkins, MD, MS, FACP
Cover of the book Current Therapy in Large Animal Theriogenology - E-Book by Robert A. Bonomo, MD, Richard R. Watkins, MD, MS, FACP
Cover of the book Kirk's Current Veterinary Therapy XV - E-Book by Robert A. Bonomo, MD, Richard R. Watkins, MD, MS, FACP
Cover of the book Hematopathology E-Book by Robert A. Bonomo, MD, Richard R. Watkins, MD, MS, FACP
Cover of the book Pediatric Head and Neck Masses, An Issue of Otolaryngologic Clinics of North America, E-Book by Robert A. Bonomo, MD, Richard R. Watkins, MD, MS, FACP
Cover of the book Flaps and Grafts in Dermatologic Surgery E-Book by Robert A. Bonomo, MD, Richard R. Watkins, MD, MS, FACP
Cover of the book Monitoring Tissue Perfusion and Oxygenation, An Issue of Critical Nursing Clinics, E-Book by Robert A. Bonomo, MD, Richard R. Watkins, MD, MS, FACP
Cover of the book Transitions in Nursing - E-Book by Robert A. Bonomo, MD, Richard R. Watkins, MD, MS, FACP
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy